For something that is only used once a week, a new study finds that the popular weight-loss drug, Ozempic, could be manufactured for much less that what is being put out there. 

Researchers say the weight-loss drug could be profitably produced for less than $5 dollars a month rather than the nearly $1,000 dollars Novo Nordisk charges the US. 

For more, KCBS Radio's Nikki Medoro spoke with Bloomberg's Robert Langreth. 

For something that is only used once a week, a new study finds that the popular weight-loss drug, Ozempic, could be manufactured for much less that what is being put out there. 
Researchers say the weight-loss drug could be profitably produced for less than $5 dollars a month rather than the nearly $1,000 dollars Novo Nordisk charges the US. 
For more, KCBS Radio's Nikki Medoro spoke with Bloomberg's Robert Langreth.

Every weekday, Emily Chang discusses the biggest news from Silicon Valley and
the intersection of tech and business with one of KCBS Radio's leading
anchors. Her appearances are highly informative to listeners as she often
breaks news and sets the agenda in her beat.
 

Advertisement